MICHELLE SITZMAN: Open Payments
NPI 1568469419 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107,721 in 268 payments from 20 companies in 2025. Trend: 2023 $38,641 · 2024 $52,673 · 2025 $107,721
Speaker / faculty: $58,891Consulting: $25,475Travel & lodging: $16,123Food & beverage: $3,656Honoraria: $3,575
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 43 | $31,077 |
| Galderma Laboratories, L.P. | 31 | $24,588 |
| ABBVIE INC. | 36 | $17,614 |
| Incyte Corporation | 32 | $10,001 |
| Regeneron Healthcare Solutions, Inc. | 28 | $9,862 |
| GENZYME CORPORATION | 7 | $6,561 |
| Organon LLC | 13 | $5,239 |
| Kowa Pharmaceuticals America, Inc. | 3 | $1,681 |
| LEO Pharma Inc. | 12 | $245 |
| E.R. Squibb & Sons, L.L.C. | 21 | $197 |
Products named: Zoryve, NEMLUVIO, DUPIXENT, RINVOQ, Opzelura, SKYRIZI, VTAMA, Sotyktu.
Industry payments across NE — which companies pay providers there.
